# Collegium Pharmaceutical, Inc: Form 8-K/A, filed Nov 14, 2024

- Company: [Collegium Pharmaceutical, Inc](/companies/coll.md) (CIK 1267565)
- Form: 8-K/A
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 16:01 ET
- Period: 2024-09-03
- Accession: 0001104659-24-118858
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1267565/000110465924118858/tm2428082d1_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1267565/000110465924118858/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1267565/000110465924118858/tm2428082d1_8ka.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-118858. Last ingested by Listed: Nov 10, 2026, 23:07 ET. No prices; not investment advice.
